中华血液学杂志
中華血液學雜誌
중화혈액학잡지
Chinese Journal of Hematology
2008年
8期
544-548
,共5页
WANG Yang%林冬%王东海%XU Zhi-fang%刘家卓%LIU Xiang-rong%王建祥%WANG Min
WANG Yang%林鼕%王東海%XU Zhi-fang%劉傢卓%LIU Xiang-rong%王建祥%WANG Min
WANG Yang%림동%왕동해%XU Zhi-fang%류가탁%LIU Xiang-rong%왕건상%WANG Min
基因,中期因子%白血病%聚合酶链反应,实时定量
基因,中期因子%白血病%聚閤酶鏈反應,實時定量
기인,중기인자%백혈병%취합매련반응,실시정량
Gene,Midkine%Leukemia%Polymerase chain reaction,real-time,quantitative
目的 检测中期因子(Midkine,MK)基因在白血病患者中的表达,初步探讨其与白血病的关系.方法 应用实时定量逆转录PCR(RQ-RT-PCR)方法,对181例急性白血病(AL)患者、31名正常人骨髓标本进行了中期因子转录本的检测.结果 中期因子在初治和复发AL患者、AL完全缓解(CR)患者及正常人骨髓细胞均有表达.初治和复发AL患者中期因子表达明显高于正常人及CR患者(P<0.01及P<0.05).而正常人与CR患者相比差异无统计学意义.中期因子的表达在B细胞急性淋巴细胞白血病(B-ALL)各亚型(包括pro-B-ALL,common-B-ALL,pre-B-ALL)及各年龄段均有显著升高(P<0.01),且与T细胞急性淋巴细胞白血病(T-ALL)、急性杂合性白血病及急性髓系白血病(AML)各FAB亚型问差异均有统计学意义(P值均<0.01);与正常人相比,M2型患者中期因子表达明显升高(P<0.01),与AML其他FAB亚型相比差异亦有统计学意义(P值均<0.05);M3患者中期因子表达也较正常人明显升高(P<0.05),但与除B-ALL和AML-M2外的其他白血病亚型间差异无统计学意义.CD34+患者较CD34-患者中期因子表达显著升高(P<0.01),AML1-ETO融合基因阳性的M2患者较阴性的M2患者中期冈子表达显著升高(P<0.05).结论 B-ALL、AML-M2和AML-M3型白血病患者中均存在中期因子基因不同程度的表达升高,为白血病诊断及其发病机制的研究提供了新的方向.
目的 檢測中期因子(Midkine,MK)基因在白血病患者中的錶達,初步探討其與白血病的關繫.方法 應用實時定量逆轉錄PCR(RQ-RT-PCR)方法,對181例急性白血病(AL)患者、31名正常人骨髓標本進行瞭中期因子轉錄本的檢測.結果 中期因子在初治和複髮AL患者、AL完全緩解(CR)患者及正常人骨髓細胞均有錶達.初治和複髮AL患者中期因子錶達明顯高于正常人及CR患者(P<0.01及P<0.05).而正常人與CR患者相比差異無統計學意義.中期因子的錶達在B細胞急性淋巴細胞白血病(B-ALL)各亞型(包括pro-B-ALL,common-B-ALL,pre-B-ALL)及各年齡段均有顯著升高(P<0.01),且與T細胞急性淋巴細胞白血病(T-ALL)、急性雜閤性白血病及急性髓繫白血病(AML)各FAB亞型問差異均有統計學意義(P值均<0.01);與正常人相比,M2型患者中期因子錶達明顯升高(P<0.01),與AML其他FAB亞型相比差異亦有統計學意義(P值均<0.05);M3患者中期因子錶達也較正常人明顯升高(P<0.05),但與除B-ALL和AML-M2外的其他白血病亞型間差異無統計學意義.CD34+患者較CD34-患者中期因子錶達顯著升高(P<0.01),AML1-ETO融閤基因暘性的M2患者較陰性的M2患者中期岡子錶達顯著升高(P<0.05).結論 B-ALL、AML-M2和AML-M3型白血病患者中均存在中期因子基因不同程度的錶達升高,為白血病診斷及其髮病機製的研究提供瞭新的方嚮.
목적 검측중기인자(Midkine,MK)기인재백혈병환자중적표체,초보탐토기여백혈병적관계.방법 응용실시정량역전록PCR(RQ-RT-PCR)방법,대181례급성백혈병(AL)환자、31명정상인골수표본진행료중기인자전록본적검측.결과 중기인자재초치화복발AL환자、AL완전완해(CR)환자급정상인골수세포균유표체.초치화복발AL환자중기인자표체명현고우정상인급CR환자(P<0.01급P<0.05).이정상인여CR환자상비차이무통계학의의.중기인자적표체재B세포급성림파세포백혈병(B-ALL)각아형(포괄pro-B-ALL,common-B-ALL,pre-B-ALL)급각년령단균유현저승고(P<0.01),차여T세포급성림파세포백혈병(T-ALL)、급성잡합성백혈병급급성수계백혈병(AML)각FAB아형문차이균유통계학의의(P치균<0.01);여정상인상비,M2형환자중기인자표체명현승고(P<0.01),여AML기타FAB아형상비차이역유통계학의의(P치균<0.05);M3환자중기인자표체야교정상인명현승고(P<0.05),단여제B-ALL화AML-M2외적기타백혈병아형간차이무통계학의의.CD34+환자교CD34-환자중기인자표체현저승고(P<0.01),AML1-ETO융합기인양성적M2환자교음성적M2환자중기강자표체현저승고(P<0.05).결론 B-ALL、AML-M2화AML-M3형백혈병환자중균존재중기인자기인불동정도적표체승고,위백혈병진단급기발병궤제적연구제공료신적방향.
Objective To analyze the expression of midkine(MK)gene in acute leukemia patients,and explore the relationship between the gene and leukemia.Methods The MK gene expression levels were detected by real-time quantitative RT-PCR(RQ-RT-PCR)in bone marrow(BM)of 181 acute leukemia(AL)patients and 31 normal controls.Results MK gene was expressed in all AL patients,normal controls and AL patients in complete remission(CR).Compared with that in control group and CR group,MK gene expression was significantly increased in AL patients(P<0.01 and P<0.05,respectively).No statistical difference was found between CR group and control group.The expression of MK showed a notable increase in aU B-ALL subtypes(including pro-B-ALL,common-B-ALL and pre-B-ALL)as well as in adult and childhood B-ALL patients(P<0.01).Moreover,the gene expression in B-ALL was also significantly higher than that in T-ALL,HAL and FAB subtypes of AML (P<0.01).In addition,M2 patients showed significantly increased in MK expression compared with that in normal controls(P<0.01)and in other FAB subtypes of AML(P<0.05).Median MK expression level in M3 patients was also significantly higher than that in normal control (P<0.05),but there was no statistical difference between M3 and other AL subtypes excepting for M2 and B-ALL.MK expression in CD34 positive patients was significantly higher than that in CD34 negative ones (P<0.01).and within M2 patients,MK expression was higher in patients with t(8;21)than in those without the translocation(P<0.05).Conclusion MK gene expression is increased with different levels in B-ALL,M2 and M3 patients,which provides novel insights into the leukemogenesis of acute leukemia.